US › Healthcare

Aurora Cannabis Inc (ACB)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.81-0.71%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$38.1M
Revenue YoY
-57.9%
Net profit
$-57.0M
Profit YoY
-132.3%
EPS
$-0.99
EPS estimate
$-0.14
Net margin
-149.7%

EPS came in at -0.99 against a street estimate of -0.14 — a miss of 607.1%.

Key statistics

Market cap
$172.8M
Forward P/E
19.2
P/B
0.47
Book value
$6.19
EPS (TTM)
$-0.73
52-week high
$6.67
52-week low
$2.56
50-day MA
$2.99
200-day MA
$3.79
Beta
1.35

Analyst view

Analysts rate Aurora Cannabis Inc a buy (4 buy, 2 hold, 0 sell out of 6) with an average price target of $6.23.

Shareholding

Insiders
1.27%
Institutions
9.84%

Largest institutional holders

FundStake
Tidal Investments LLC.2.02%
The Goldman Sachs Group Inc1.71%
Renaissance Technologies Corp1.22%
NATIONAL BANK OF CANADA /FI/0.44%
Morgan Stanley - Brokerage Accounts0.42%
Citadel Advisors Llc0.41%
AdvisorShares Investments, LLC0.28%
UBS Group AG0.25%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Aurora Cannabis Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.